Neuland Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

12.90

12.90

12.90

12.90

12.90

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

974.63

821.83

768.14

691.81

681.84

Loan funds

Secured loans

121.51

230.95

145.12

245.55

209.77

Unsecured loans

-

-

-

-

-

Total

1,109.04

1,065.68

926.16

950.25

904.51

Uses of funds

Fixed assets

Gross block

962.38

926.86

837.69

740.85

602.95

Less : revaluation reserve

0.84

0.84

0.84

0.84

0.84

Less : accumulated depreciation

204.84

159.50

121.86

88.28

61.46

Net block

756.70

766.52

714.99

651.73

540.65

Capital work-in-progress

40.57

20.46

17.25

23.75

104.47

Investments

0.68

4.03

7.05

8.02

8.06

Net current assets

Current assets, loans & advances

780.55

590.27

583.39

545.41

475.88

Less : current liabilities & provisions

469.46

315.60

396.52

278.65

224.54

Total net current assets

311.09

274.67

186.86

266.76

251.33

Miscellaneous expenses not written

-

-

-

-

-

Total

1,109.04

1,065.68

926.16

950.25

904.51

Notes:

Book value of unquoted investments

0.41

3.78

6.86

7.91

8.06

Market value of quoted investments

-

0.25

-

-

-

Contingent liabilities

100.72

92.99

127.52

134.68

24.05

Number of equity sharesoutstanding (Lacs)

128.30

128.30

128.30

128.30

128.30